Single-Injection Intravitreal Bevacizumab Versus bevacizumab–triamcinolone for Diabetic Macular Edema: A Prospective Comparative Observational Study Evaluating Efficacy, Durability and Intraocular Pressure Safety During 12 Weeks of Follow-Up. SJ-Ophthalmology 2026, 3 (3), 9. https://doi.org/10.51168/w9sfw022.